Sharmin Haideri

Research Scientist

Share

Dr. Sharmin Haideri is an internationally recognized stem cell scientist and regenerative medicine innovator, with over a decade of extensive pioneering research experience within Canada and the UK. She earned her PhD from the renowned Scottish Centre for Regenerative Medicine, at the University of Edinburgh, where she conducted trailblazing research on pluripotent stem cell-derived macrophages for liver fibrosis under the mentorship of Dr. Lesley Forrester and Dr. Stuart Forbes. Her formative years in science were guided by Sir Ian Wilmut, the iconic scientist who revolutionized the field of stem cell research and regenerative medicine, and led the creation of Dolly the sheep.

Driven by scientific curiosity and a deep commitment to medical innovation, Dr. Haideri completed a prestigious post-doctoral fellowship at the University Health Network (UHN), Canada’s #1 research hospital. Under the mentorship of Dr. Cristina Nostro, she carried out groundbreaking research developing stem cell-derived pancreatic beta cells for type 1 diabetes, redefining potential therapies for chronic and life-altering diseases.

Dr. Haideri is a recognized expert in cellular reprogramming, directed differentiation, CRISPR gene editing, lentiviral vector systems, and custom cell line engineering. Her technical expertise is matched by a strategic vision for translating complex scientific advances into viable clinical products. Her certification in the commercialization of cell products from the University of Toronto and the Rotman School of Management equips her with a rare blend of scientific and business acumen.

Complementing her scientific expertise, Dr. Haideri is committed to supporting the regulatory pathways essential for translating cellular therapies from research labs to clinical trials. She completed a specialized course in regulatory literacy through the Stem Cell Network in partnership with WeCANReg Inc., strengthening her ability to navigate the intricate global regulatory frameworks that guide the development of advanced therapeutics. Her mission is to bridge the gap between scientific discovery and clinical application, advancing life-changing therapies through rigorous research and regulatory excellence.